Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

University of Michigan Rogel Cancer Center

Status: Completed

Conditions: Breast Cancer

Treatments: Behavioral: Breast cancer decision aid

Study type: Interventional

Funder types: Other

Identifiers

NCT05140252

HUM00195321 (Other Identifier)

UMCC 2021.087

Details and patient eligibility

About

The aim of this study is to learn whether participants find a patient guide to breast cancer treatment decisions acceptable and appropriate for use.

Full description

This study seeks to adapt and pilot test de-implementation strategies targeting low-value breast cancer treatments which have persisted despite national recommendations. Breast cancer is an ideal setting in which to study de-implementation given it is common, well-studied, typically presents at an early-stage, and care is provided primarily in a community setting.

Enrollment: 22 patients

Sex: Female

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Early stage breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor negative (HER2-)
• Meet criteria for omission of sentinel lymph node biopsy (SLNB)
• Receiving care at Michigan Medicine

Exclusion Criteria

• Non-English speaking
• Male patients (current data does not support omission of SLNB in men)

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Breast cancer decision aid

Experimental group

Description:

Participants receive a breast cancer decision aid.

Treatment:

Behavioral: Breast cancer decision aid